Institutional Ownership
Lineage Cell Therapeutics In
CUSIP 53566P109COMLCTXQ1 2026
13D / 13G Filings
14
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
24.5%
Max % of class reported
Institutional Holders
127
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
14 filings · latest Nov 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 14, 2025 | Broadwood Partners, L.P. | 13D/A | 23.1% | — | SEC |
| 2 | Sep 26, 2025 | Chernett Jorey | 13G | 5.0% | 11.45M | SEC |
| 3 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 1.0% | 2.23M | SEC |
| 4 | Apr 24, 2025 | Blackrock, Inc. | 13G | 5.0% | 11.45M | SEC |
| 5 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 4.6% | 10.09M | SEC |
| 6 | Jan 28, 2025 | Broadwood Partners, L.P. | 13D/A | 24.5% | — | SEC |
| 7 | Nov 21, 2024 | Broadwood Partners, L.P. | 13D/A | 18.9% | 41.67M | SEC |
| 8 | Nov 8, 2024 | Blackrock, Inc. | 13G | 5.3% | 9.92M | SEC |
| 9 | Oct 22, 2024 | Blackrock, Inc. | 13G | 5.3% | 9.92M | SEC |
| 10 | Feb 8, 2024 | Broadwood Partners, L.P. | 13D/A | 22.1% | 41.67M | SEC |
4 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Lineage Cell Therapeutics In.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Broadwood Capital Inc | 49.56M | $78.31M |
| 2 | Defender Capital, LLC. | 6.73M | $10.63M |
| 3 | Millennium Management LLC | 5.56M | $8.79M |
| 4 | Raffles Associates LP | 5.36M | $8.47M |
| 5 | Fifth Third Bancorp | 4.60M | $7.27M |
| 6 | Blackrock, Inc. | 3.86M | $6.11M |
| 7 | Armistice Capital, LLC | 3.18M | $5.03M |
| 8 | Marshall Wace, LLP | 3.07M | $4.84M |
| 9 | Geode Capital Management, LLC | 2.52M | $3.99M |
| 10 | Renaissance Technologies LLC | 2.13M | $3.36M |